Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Summit Therapeutics (SMMT) up 28% after its study of ivonescimab demonstrated a statistically significant 5.3 months of improvement in progression free survival versus Keytruda
- Boeing (BA) up 3% after reaching a tentative agreement on a contract offer with IAM Districts 751 & W24, which represent 33,000-plus Boeing employees
- Tesla (TSLA) up 2% after Elon Musk denied a Wall Street Journal report that his xAI has held talks for a share in future Tesla revenue in return for giving the EV maker access to technology and resources
- Wex (WEX) up 2% after announcing that its board of directors has authorized an amended share repurchase program under which up to an additional $1B may be bought back
- Eli Lilly (LLY) up 1% after appointing Lucas Montarce as executive vice president and CFO
UP AFTER EARNINGS –
LOWER –
- Big Lots (BIG) down 44% after reporting that it has entered into an agreement with an affiliate of Nexus Capital, pursuant to which Nexus has agreed to acquire substantially all of the company’s assets and ongoing business operations and the company, together with each of its subsidiaries, initiated voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware
- Methanex (MEOH) down 8% after entering into a definitive agreement to acquire OCI Global’s international methanol business for $2.05B
- Merck (MRK) down 2% after Summit’s study of ivonescimab demonstrated a statistically significant 5.3 months of improvement in progression free survival versus Keytruda
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BA: